DEPPERT WOLFGANG WILLI has a total of 19 patent applications. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are IMMUNE TARGETING INC, CURTIS RORY A J and CRESCENDO BIOLOGICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Hungary | 1 | |
#7 | Mexico | 1 | |
#8 | Norway | 1 | |
#9 | Poland | 1 | |
#10 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Deppert Wolfgang Willi | 15 |
#2 | Kim Ella | 7 |
#3 | Dornreiter Irene | 3 |
Publication | Filing date | Title |
---|---|---|
EP1570733A1 | Mammal for studying DCIS and the effect of inactivated tumor suppressors | |
EP1462521A1 | Human p53 splice variant displaying differential transcriptional activity | |
EP1049810A2 | INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53 | |
HU0002766A3 | Method for influencing the p53 linkage in target genes | |
EP0783324A1 | Cellular immunity-inducing conjugate |